Skip to content

Firefighter Collaborative Research Project

Firefighter Collaborative Research Project

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05869747
Acronym
FCRP
Enrollment
1500
Registered
2023-05-22
Start date
2023-06-22
Completion date
2025-12-31
Last updated
2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary, Exposure

Keywords

Firefighters

Brief summary

The goal of this research is to test interventions to reduce firefighter cardiovascular, cognitive, and overall disease risks, including but not limited to risks associated with Per- and Polyfluorinated Substances (PFAS) exposure. Approximately 1,500 - 2,000 firefighters will be enrolled in the Fire Fighter Cancer Cohort Study (FFCCS). Among these individuals, those that express interest will then be screened for eligibility for the Firefighter Collaborative Research Project (FCRP) using information they provided for the Fire Fighter Cancer Cohort Study. Firefighters enrolled in the study will provide an initial blood sample and urine sample. The blood sample will be analyzed to determine the participant's PFAS levels. Based upon serum PFAS levels and responses from the screening survey, eligible participants will be randomly assigned into one of the following interventions: 1. Blood Donation, or Plasma Donation or Blood/Plasma Control Group; 2. Zone 2 Training or Zone 2 Control; 3. Intermittent Fasting or Intermittent Fasting Control. Individuals participating in the blood donation, plasma donation or blood/plasma control group would donate blood every 12 weeks, plasma every 6 weeks, or not donate blood or plasma. Participants in this intervention arm would continue this for a 12-month period. Individuals in the zone 2 training, zone 2 training control, intermittent fasting or intermittent fasting control group would participate in their intervention or control for a 4-month period. After 4 to 12 months participating in an intervention or control group, participants will be asked to provide a final urine sample and blood draw to determine if and to what degree their PFAS levels or other cardiovascular disease and other health risks have changed.

Interventions

BEHAVIORALBlood Donation

Participants asked to donate whole blood at a donation facility from a list provided by the study.

BEHAVIORALPlasma Donation

Participants asked to donate plasma at a donation facility from a list provided by the study.

BEHAVIORALZone 2 Training

Participants asked to work out in their custom Zone 2 heart range 4 times a week for 45 to 60 minutes.

BEHAVIORALIntermittent Fasting

Participants asked to engage in an intermittent fasting routine of a 16 hour fast followed by an 8 hour eating period at least 4 times a week.

BEHAVIORALSurveys

Participants were asked to complete surveys throughout the study to monitor intervention progress and to collect baseline and end-of-study data.

Sponsors

Arizona State University
CollaboratorOTHER
University of Arizona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Active firefighter (including emergency medical responder and all firefighter subgroups) with either a volunteer or career status * Individual plans to remain in active service with their current agency for the next 2 years (not planning to retire or resign) * 18 years of age and older * Fluently speak and write in English * All sexes, races, and ethnicities * Enrolled in the Fire Fighter Cancer Cohort Study (FFCCS) prior to enrolling in the Firefighter Collaborative Research Project (FCRP) * Complete a signed and dated informed consent document that indicates the participant has been informed of all aspects of the study prior to enrollment * Agree to avoid participating in FCRP intervention activities outside of their assigned intervention group for the duration of the study * Able to comply with scheduled visits, laboratory tests and other study procedures * BMI of 17.5 kg/m2 or greater and be greater than 115 pounds * Must also be eligible to donate blood and blood-based products if randomized into the blood or plasmapheresis intervention groups

Exclusion criteria

from overall study: * Not able to fluently speak or write in English * Less than 18 years of age * Currently a tobacco smoker or vaping (e.g. \>2 cigarettes or cigars, or incidents of vaping in the past month) * Those with planned travel or extended leave (e.g. \>6 weeks) that would prevent their ability to participate in other interventions * Those who are pregnant, breastfeeding, or have given birth within the past year * Those with a history or diagnosis of any significant metabolic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurological, immune, hepatic, renal, urological disorders, severe injury or cancer that, in the opinion of the investigator, would potentially put the candidate at risk.

Design outcomes

Primary

MeasureTime frameDescription
Change in concentration of PFAS levels in serum12 monthsPFAS levels are per- and polyfluoroalkyl substance levels measured from a biological sample
Change in epigenetic age4 monthsEpigenetic age is a mathematically derived age estimators that are based on combinations of methylation values that change with age at specific CpGs in the genome.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026